Embecta Corp. (EMBC) Insider Buying
Every C-suite and executive open-market purchase of Embecta Corp. stock we've tracked from SEC Form 4 filings — each scored on our six-factor model. Not financial advice.
Tracked buys
3
Total value
$334,097
Most recent
Aug 12, 2026
| Ticker | Insider | Role | Value | Filed | Signal | Score |
|---|---|---|---|---|---|---|
| EMBC Embecta Corp. | Mann Jeffrey Z | Pres, Pharm Svc&Prod Mgmt, CLO | $99,800 | Aug 13, 2026 | BUY | 61 |
| EMBC Embecta Corp. | Elguicze Jacob | SVP and CFO | $93,360 | Aug 13, 2026 | WATCH | 46 |
| EMBC Embecta Corp. | Kurdikar Devdatt | President and CEO | $140,937 | Aug 13, 2026 | WATCH | 51 |
What this page tracks
This is a live record of open-market stock purchases by directors and officers of Embecta Corp., sourced directly from SEC EDGAR Form 4 filings. We only count open-market buys — not option exercises or grants — because a personal-money purchase is the cleanest insider conviction signal.
Each filing is scored with our six-factor methodology (fundamentals, financials, technicals, conviction, CEO history, and cluster activity). See how the resulting signals performed against the S&P 500 on the track record, or browse this week's insider buys and the full signal screener.
Not financial advice. For educational purposes only. Form 4 data can be amended or filed late; analysis is generated using AI and may contain errors. Always do your own due diligence.